Baclofen for alcohol withdrawal: not comparable to the gold standard (benzodiazepines). 2007

Richard Saitz

UI MeSH Term Description Entries
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000431 Ethanol A clear, colorless liquid rapidly absorbed from the gastrointestinal tract and distributed throughout the body. It has bactericidal activity and is used often as a topical disinfectant. It is widely used as a solvent and preservative in pharmaceutical preparations as well as serving as the primary ingredient in ALCOHOLIC BEVERAGES. Alcohol, Ethyl,Absolute Alcohol,Grain Alcohol,Alcohol, Absolute,Alcohol, Grain,Ethyl Alcohol
D001418 Baclofen A GAMMA-AMINOBUTYRIC ACID derivative that is a specific agonist of GABA-B RECEPTORS. It is used in the treatment of MUSCLE SPASTICITY, especially that due to SPINAL CORD INJURIES. Its therapeutic effects result from actions at spinal and supraspinal sites, generally the reduction of excitatory transmission. Baclophen,Chlorophenyl GABA,Apo-Baclofen,Atrofen,Ba-34,647,Ba-34647,Baclofen AWD,Baclofène-Irex,Baclospas,CIBA-34,647-BA,Clofen,Gen-Baclofen,Genpharm,Lebic,Lioresal,Liorésal,Nu-Baclo,PCP-GABA,PMS-Baclofen,beta-(Aminomethyl)-4-chlorobenzenepropanoic Acid,beta-(p-Chlorophenyl)-gamma-aminobutyric Acid,AWD, Baclofen,Apo Baclofen,ApoBaclofen,Ba34,647,Ba34647,Baclofène Irex,BaclofèneIrex,CIBA34,647BA,GABA, Chlorophenyl,Gen Baclofen,GenBaclofen,Nu Baclo,NuBaclo,PMS Baclofen,PMSBaclofen
D001569 Benzodiazepines A group of two-ring heterocyclic compounds consisting of a benzene ring fused to a diazepine ring. Benzodiazepine,Benzodiazepine Compounds
D013375 Substance Withdrawal Syndrome Physiological and psychological symptoms associated with withdrawal from the use of a drug after prolonged administration or habituation. The concept includes withdrawal from smoking or drinking, as well as withdrawal from an administered drug. Drug Withdrawal Symptoms,Withdrawal Symptoms,Drug Withdrawal Symptom,Substance Withdrawal Syndromes,Symptom, Drug Withdrawal,Symptom, Withdrawal,Symptoms, Drug Withdrawal,Symptoms, Withdrawal,Syndrome, Substance Withdrawal,Syndromes, Substance Withdrawal,Withdrawal Symptom,Withdrawal Symptom, Drug,Withdrawal Symptoms, Drug,Withdrawal Syndrome, Substance,Withdrawal Syndromes, Substance
D018755 GABA Agonists Endogenous compounds and drugs that bind to and activate GAMMA-AMINOBUTYRIC ACID receptors (RECEPTORS, GABA). gamma-Aminobutyric Acid Agonists,GABA Agonist,GABA Receptor Agonist,GABA Receptor Agonists,gamma-Aminobutyric Acid Agonist,Acid Agonist, gamma-Aminobutyric,Acid Agonists, gamma-Aminobutyric,Agonist, GABA,Agonist, GABA Receptor,Agonist, gamma-Aminobutyric Acid,Agonists, GABA,Agonists, GABA Receptor,Agonists, gamma-Aminobutyric Acid,Receptor Agonist, GABA,Receptor Agonists, GABA,gamma Aminobutyric Acid Agonist,gamma Aminobutyric Acid Agonists

Related Publications

Richard Saitz
June 2007, The American journal of medicine,
Richard Saitz
November 2019, The Cochrane database of systematic reviews,
Richard Saitz
February 2013, The Cochrane database of systematic reviews,
Richard Saitz
January 2011, The Cochrane database of systematic reviews,
Richard Saitz
April 2015, The Cochrane database of systematic reviews,
Richard Saitz
August 2017, The Cochrane database of systematic reviews,
Richard Saitz
March 2010, The Cochrane database of systematic reviews,
Richard Saitz
July 2005, The Cochrane database of systematic reviews,
Richard Saitz
April 2006, American family physician,
Richard Saitz
January 2019, Indian journal of psychiatry,
Copied contents to your clipboard!